Found: 20
Select item for more details and to access through your institution.
Early Response Assessment in Advanced Stage Melanoma Treated with Combination Ipilimumab/Nivolumab.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.860421
- By:
- Publication type:
- Article
Advanced basal cell carcinoma, the hedgehog pathway, and treatment options - role of smoothened inhibitors.
- Published in:
- Biologics: Targets & Therapy, 2015, v. 9, p. 129, doi. 10.2147/BTT.S54179
- By:
- Publication type:
- Article
Increased myositis and possible myocarditis in melanoma patients treated with immune checkpoint inhibitors in the COVID-19 era.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03803-5
- By:
- Publication type:
- Article
Increased myositis and possible myocarditis in melanoma patients treated with immune checkpoint inhibitors in the COVID-19 era.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03803-5
- By:
- Publication type:
- Article
Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 3, p. e224304, doi. 10.1001/jamanetworkopen.2022.4304
- By:
- Publication type:
- Article
Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 1, p. e2142046, doi. 10.1001/jamanetworkopen.2021.42046
- By:
- Publication type:
- Article
Exploring Adolescent and Young Adult Cancer Survivors' Experience with Cancer Treatment-Related Symptoms: A Qualitative Analysis of Semi-Structured Interviews.
- Published in:
- Journal of Adolescent & Young Adult Oncology, 2024, v. 13, n. 4, p. 665, doi. 10.1089/jayao.2024.0053
- By:
- Publication type:
- Article
Prognostic Hematologic Biomarkers Following Immune Checkpoint Inhibition in Metastatic Uveal Melanoma.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5789, doi. 10.3390/cancers14235789
- By:
- Publication type:
- Article
Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study.
- Published in:
- Cancers, 2022, v. 14, n. 17, p. 4334, doi. 10.3390/cancers14174334
- By:
- Publication type:
- Article
Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10708-6
- By:
- Publication type:
- Article
Metastatic melanoma of the heart: Retrospective cohort study and systematic review of prevalence, clinical characteristics, and outcomes.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 3, p. 2356, doi. 10.1002/cam4.5058
- By:
- Publication type:
- Article
Systemic Therapy for Inoperable and Metastatic Basal Cell Cancer.
- Published in:
- Current Treatment Options in Oncology, 2013, v. 14, n. 2, p. 237, doi. 10.1007/s11864-013-0233-9
- By:
- Publication type:
- Article
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 224, p. 1, doi. 10.1126/scitranslmed.3007094
- By:
- Publication type:
- Article
Validation of the American Joint Committee on Cancer Eighth Edition Staging of Patients With Metastatic Cutaneous Melanoma Treated With Immune Checkpoint Inhibitors.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 3, p. e210980, doi. 10.1001/jamanetworkopen.2021.0980
- By:
- Publication type:
- Article
Ipilimumab and Its Toxicities: A Multidisciplinary Approach.
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 733, doi. 10.1634/theoncologist.2012-0483
- By:
- Publication type:
- Article
Treatment related toxicities with combination BRAF and MEK inhibitor therapy in resected stage III melanoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.855794
- By:
- Publication type:
- Article
Liver injury is most commonly due to hepatic metastases rather than drug hepatotoxicity during pembrolizumab immunotherapy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 800, doi. 10.1111/apt.15413
- By:
- Publication type:
- Article
The impact of BRAF mutation status on clinical outcomes with anti‐PD‐1 monotherapy versus combination ipilimumab/nivolumab in treatment‐naïve advanced stage melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2021, v. 34, n. 3, p. 629, doi. 10.1111/pcmr.12944
- By:
- Publication type:
- Article
Effectively targeting BRAF in melanoma: a formidable challenge.
- Published in:
- Pigment Cell & Melanoma Research, 2008, v. 21, n. 4, p. 410, doi. 10.1111/j.1755-148X.2008.00485.x
- By:
- Publication type:
- Article